CFH and neoplasm: While the role of CFH, as an inhibitor of extracellular complement activation, in tumor progression appears to be very much model/context dependent, silencing of intracellular CFH in RCC cell lines results in cell-cycle arrest and death of tumor cells (Figure 1) (Daugan, Revel, Thouenon, et al., 2021).